Table 3.
Champions and role delineation to mainstream genetic testing for colorectal and endometrial cancer in the oncology setting.
| Statement agreement | GHP (%) | OHP (%) |
|---|---|---|
| Implementation climate and readiness to implement | ||
| Genetic Counsellors are best placed to facilitated initial adoption of routine genetic testing | 35/43 (81%) | 66/109 (61%) |
| Oncologists are best placed to integrate genetic testing over the long term | 26/44 (59%) | 58/109 (53%) |
| Surgeons are best placed to integrate genetic testing over the long term | 13/44 (30%) | 42/109 (39%) |
| Nurses are best placed to integrate genetic testing over the long term | 11/44 (25%) | 27/109 (25%) |
| Planning and engaging relevant stakeholders | ||
| Oncologists can take on the role of pre-test genetic counselling, consent and ordering genetic testing | 23/42 (55%) | 61/107 (57%) |
| Surgeons can take on the role of pre-test genetic counselling, consent and ordering genetic testing | 14/42 (33%) | 52/107 (49%) |
| Nurses can take on the role of pre-test genetic counselling, consent and ordering genetic testing | 16/40 (40%) | 38/107 (36%) |
| Pathologists can take on the role to trigger an alert from pathology reports for genetic testing | 34/42 (81%) | 65/107 (61%) |
| Genetic counsellor can facilitate tracking of results and follow-up patients | 28/42 (67%) | 94/107 (88%) |
| Any oncology staff can facilitate tracking of results and follow-up patients | 17/41 (41%) | 56/106 (55%) |